Get started
Author

Olami Sobande

Observed names: O Sobande, O. Sobande
Observed institution: AstraZeneca (United States)
OpenAlex ID: A5114495765
As-Needed Albuterol–Budesonide in Mild Asthma
2025 · Craig LaForce, Frank Albers, et al. · New England Journal of Medicine · 48
A phase 1 study evaluating the safety, tolerability, and pharmacokinetics of the porcupine inhibitor, AZD5055
2025 · Xiao-Hong Zhou, Susanne Prothon, et al. · iScience · 4
Budesonide/formoterol fumarate dihydrate versus budesonide with a novel suspension technology for uncontrolled asthma: phase 3 VATHOS study
2026 · David J. Jackson, Robert A. Wise, et al. · ERJ Open Research · 1
Batura: A fully virtual randomized controlled study of as-needed albuterol-budesonide vs albuterol in mild asthma
2024 · C. LaForce, F. Albers, et al. · Annals of Allergy Asthma & Immunology · 1
A First-in-human Study in Healthy Volunteers Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5055, A Novel Oral Porcupine Inhibitor Under Development as a Treatment for Pulmonary Fibrosis
2024 · C.A. Owen, X.-H. Zhou, et al. · American Journal of Respiratory and Critical Care Medicine · 1
As-needed Albuterol-budesonide Reduces Exacerbation Risk at GINA Step 3 and Steps 4 and 5
2026 · Richard Beasley, Bradley E. Chipps, et al. · The Journal of Allergy and Clinical Immunology In Practice
Budesonide/formoterol fumarate dihydrate versus budesonide with a novel suspension technology for uncontrolled asthma: phase 3 LITHOS study
2026 · Alberto Papi, Robert A. Wise, et al. · ERJ Open Research
A32-41 As-needed Albuterol-budesonide Decreases Risk of Severe Asthma Exacerbation in Patients ≥18 Years of Age Using Either GINA Step-3 or GINA Step 4 + 5 Maintenance Therapies: MANDALA Post-hoc Analysis
2026 · A Papi, B E Chipps, et al. · American Journal of Respiratory and Critical Care Medicine
B22-23 Albuterol-budesonide Rescue Enhances Improvements in Control Compared With Albuterol Rescue for Patients With Mild Asthma
2026 · A Papi, B E Chipps, et al. · American Journal of Respiratory and Critical Care Medicine
Efficacy and safety of as-needed albuterol–budesonide versus albuterol in patients with asthma aged 12 to <18 years: design of the randomised, double-blind, parallel-group phase IIIb ACADIA trial
2026 · Leonard Benjamin Bacharier, Hengameh Raissy, et al. · BMJ Open Respiratory Research
PDF
Efficacy of Albuterol-budesonide vs Albuterol in Mild Asthma on Disease Control Over Time
2026 · Kevin Murphy, Alberto Papi, et al. · Journal of Allergy and Clinical Immunology
As-needed Albuterol-budesonide Decreases Risk of Severe Asthma Exacerbation in the First Three Months Post-randomization Compared to As-needed Albuterol in Patients Treated for Moderate-to-Severe Asthma: MANDALA Post-Hoc Analysis
2025 · B.E. Chipps, A. Papi, et al. · American Journal of Respiratory and Critical Care Medicine
Efficacy of As-needed Albuterol-Budesonide Versus Albuterol on Systemic Corticosteroid Exposure in Participants With Mild Asthma: BATURA Prespecified Analysis
2025 · R.A. Panettieri, L. Bacharier, et al. · American Journal of Respiratory and Critical Care Medicine
Efficacy Of As-needed Albuterol‒Budesonide Versus Albuterol By Baseline Therapy In Participants With Mild Asthma: BATURA Pre-specified Analysis
2025 · Monica Kraft, Craig LaForce, et al. · Journal of Allergy and Clinical Immunology
PDF
Works count: 14
Citation count: 55
H-index: 2
I10-index: 1
Year
Topic
Type